阿托伐他汀对急性ST段抬高型心肌梗死患者尿激酶溶栓疗效

阿托伐他汀对急性ST段抬高型心肌梗死患者尿激酶溶栓疗效毛剑辉;刘迟
【期刊名称】《中国医药导报》
【年(卷),期】2014(000)020
【摘要】目的：探讨阿托伐他汀对急性ST段抬高型心肌梗死患者尿激酶溶栓疗效。

方法分析同济大学附属同济医院2008年1月~2013年12月收治的60例急性
ST段抬高型心肌梗死患者临床资料，依据治疗措施不同进行临床分组，常规治疗
组(通过常规的溶栓治疗)30例和观察组(在常规溶栓前给予阿托伐他汀)30例。

观
察两组患者治疗前后超敏C反应蛋白(hs-CRP)、白介素-6(IL-6)和肿瘤坏死因子-
α(TNF-α)变化情况，观察两组患者胸痛缓解时间、ST段回落、酶峰出现时间和再灌注心律失常情况。

结果两组治疗前hs-CRP、IL-6和TNF-α比较差异无统计学
意义(t=0.23、0.20、0.17，均P>0.05)，观察组治疗后hs-CRP、IL-6和TNF-α
均优于常规治疗组(t=3.81、33.00、23.08，均P<0.05)，观察组胸痛缓解时间、ST段回落、酶峰出现时间和再灌注心律失常均优于常规治疗组，差异均有统计学
意义(t=2.45、3.04、3.01、4.90，均P<0.05)。

结论阿托伐他汀在急性ST段抬
高型心肌梗死患者中的应用可以提高患者尿激酶溶栓治疗效果，降低复发率，值得临床推广应用。

%Objective To investigate the effect of the thrombolytic therapy of acute ST segment elevation myocardial infarction patients by Atovatatin. Methods The clinical data of 60 cases of patients with acute ST segment elevation myocardial infarction admitted to Tongji Hospital Affiliated to Tongji University was analyzed, according to different treating methods, the patients were divided into two groups, 30 cases of
conventional treatment group (through conven-tional thrombolysis treatment) and 30 cases of observation group (in conventional Atorvastatin before thrombolysis). The hs-CRP, IL-6 and TNF-α before and after treatment of two groups were detected. The chest pain relief time, ST-seg-ment resolution, enzyme peak appearing time and reperfusion arrhythmia of two groups were detected. Results The hs-CRP, IL-6 and TNF-α before treatment of two groups were not statistically different (t = 0.23, 0.20, 0.17, P> 0.05), hs-CRP, IL-6 and TNF-αafter treatment of observation group were better than conventional treatment group (t=3.81, 33.00, 23.08, P< 0.05). The chest pain relief time, ST-segment resolution, enzyme peak appearing time and reperfu-sion arrhythmia observation group acute ST segment elevation myocardial infarction patients were better than conven-tional treatment group, the differences were statistically significant (t = 2.45, 3.04, 3.01, 4.90, all P< 0.05). Conclu-sion The effect of urokinase thrombolysis treatment acute ST segment elevation myocardial infarction patients by Ato-vatatin is improved, recurrence rate is decreased, which is worthy to be used in clinic.
【总页数】4页(P75-78)
【作者】毛剑辉;刘迟
【作者单位】同济大学附属同济医院急诊科，上海 200065;上海静安区中心医院老年科，上海 200040
【正文语种】中文
【中图分类】R542.22
【相关文献】
1.阿托伐他汀对急性ST段抬高型心肌梗死患者尿激酶溶栓疗效的影响 [J], 陈德春;王虹艳;曲鹏;刘珍竹
2.波立维联合尿激酶溶栓对急性ST段抬高型心肌梗死患者的疗效及预后分析 [J], 张燕清;陈瑜;刘志隆;凌观娇
3.大剂量阿托伐他汀对急性ST段抬高型心肌梗死患者尿激酶溶栓疗效的观察 [J], 唐莉
4.波立维联合尿激酶溶栓对急性ST段抬高型心肌梗死患者的疗效及预后分析 [J], 张燕清;陈瑜;刘志隆;凌观娇
5.急性ST段抬高型心肌梗死患者在溶栓治疗中分别应用瑞替普酶和尿激酶的临床治疗效果 [J], 邱茹玲
因版权原因，仅展示原文概要，查看原文内容请购买。